![Hannah Chandler](https://profiles-cardiff.imgix.net/attachments/274?w=200&h=200&auto=format&crop=faces&fit=crop&q=90")
Hannah Chandler
- Ar gael fel goruchwyliwr ôl-raddedig
Timau a rolau for Hannah Chandler
Cydymaith Ymchwil
Trosolwyg
Crynodeb ymchwil
Mae'r ymennydd yn gofyn am gyflenwad cyson o egni, lle mae angen coreograffu llif y gwaed trwy rwydwaith cymhleth o bibellau gwaed i ateb gofynion ynni meinwe. Mae fy ymchwil wedi datgelu bod unigolion ifanc sydd â mwy o risg genetig ar gyfer clefyd Alzheimer (AD) wedi lleihau llif gwaed yr ymennydd yn sylweddol sy'n parhau i fod yn gyson ar draws y rhychwant oes, lle mae mynegiant genynnau risg AD rhanbarthol uwch yn gysylltiedig â llai o lif gwaed yr ymennydd. Mae fy ymchwil ynghyd ag eraill ym maes dementia wedi dangos bod dadansoddiad yn rheoleiddio system fasgwlaidd yr ymennydd yn un o'r newidiadau cynharaf y gellir eu canfod yng nghlwy'r clefyd Alzheimer. Felly, gall targedu system fasgwlaidd yr ymennydd ar gyfer strategaethau ataliol helpu i liniaru dysregulation fasgwlaidd yn y rhai sydd mewn perygl, ac oedi dilyniant pathoffisioleg sy'n gysylltiedig ag AD.
Rwyf wedi cefnogi dilysu dulliau MRI newydd sydd â chyfleustodau clinigol ar gyfer diagnosio dysregulation fasgwlaidd mewn clefydau. Rwyf bellach yn cymhwyso'r dulliau delweddu MRI newydd hyn i nifer o garfannau clinigol gan gynnwys sglerosis ymledol, dementia, epilepsi, ac arthritis gwynegol. Mae fy ngwaith hefyd yn cynnwys defnyddio methodolegau delweddu PET i asesu ffisioleg yr ymennydd. Fel ECR mewn delweddu PET, rwyf wedi ymuno â Dr Mattia Veronese a'r Athro Federico Turkheimer yng Ngholeg y Brenin, Llundain, lle gwnaethom gyd-sefydlu Partneriaeth PET y DU (PPUK). Datblygwyd y PPUK i alluogi cydweithrediadau ar raddfa fwy ledled y DU a thu hwnt i fynd i'r afael â chwestiynau ymchwil pwysig wrth astudio clefydau. Mae hefyd yn darparu adnodd i ECR ddod o hyd i gymorth gyda dylunio astudiaeth ddelweddu PET, casglu a dadansoddi data.
Ar gyfer PPUK gweler: https://petpartnershipuk.com
Cyhoeddiad
2026
- Wright, M. E. et al. 2026. Endocrine modulation of cortical and retinal baseline perfusion across the menstrual cycle. Journal of Cerebral Blood Flow and Metabolism 46 (7), pp.1889-1904. (10.1177/0271678X261421106)
- Davis, R. et al. 2026. Impact of apolipoprotein Ε4 (APOE ε4) on neuroimaging outcomes in cognitively healthy midlife adults: A systematic review. NeuroImage: Clinical 51 104035. (10.1016/j.nicl.2026.104035)
- Chandler, H. L. et al. 2026. Imaging brain vascular function in Cystic Fibrosis: an MRI study of cerebral blood flow and brain oxygenation. Journal of Cystic Fibrosis 25 (1), pp.166-171. (10.1016/j.jcf.2025.08.010)
2025
- Lancaster, T. M. , Murphy, K. and Chandler, H. 2025. Reductions in brainstem volume as a key macrostructural indicator in at-risk populations for Alzheimer’s disease. Alzheimer's Research and Therapy 17 (1) 177. (10.1186/s13195-025-01829-0)
- Wood, L. et al. 2025. Brain age is stable across the menstrual cycle: results from a high-density sampling study. Presented at: ISMRM & ISMRT Annual Meeting and Exhibition Honolulu, Hawaii, USA 10-15 May 2025. Proceedings of the 2025 ISMRM & ISMRT Annual Meeting and Exhibition. (10.58530/2025/4889)
- Frost, F. J. et al., 2025. Managing an ageing cystic fibrosis population: challenges and priorities. European Respiratory Review 34 (176) 240261. (10.1183/16000617.0261-2024)
- Driver, I. D. et al. 2025. Velocity-selective arterial spin labelling bolus duration measurements: Implications for consensus recommendations. Imaging Neuroscience 3 00506.. (10.1162/imag_a_00506)
- Chandler, H. L. et al. 2025. Non‐APOE variants predominately expressed in smooth muscle cells contribute to the influence of Alzheimer's disease genetic risk on white matter hyperintensities. Alzheimer's & Dementia: The Journal of the Alzheimer's Association 21 (2) e14455. (10.1002/alz.14455)
- McNabb, C. B. et al. 2025. WAND: A multi-modal dataset integrating advanced MRI, MEG, and TMS for multi-scale brain analysis. Scientific Data 12 220. (10.1038/s41597-024-04154-7)
2024
- Driver, I. D. et al. 2024. Breath-hold calibrated fMRI mapping of absolute cerebral metabolic rate of oxygen metabolism (CMRO2): an assessment of the accuracy and repeatability in a healthy adult population. Imaging Neuroscience 2 , pp.1-14. (10.1162/imag_a_00298)
- Wright, M. E. et al. 2024. OP-07 Retinal and cortical vascular function across the menstrual cycle. Presented at: Women in Vision UK Winter Meeting 2023 Cambridge, UK 12 December 2023. Vol. 9.(10.1136/bmjoo-2024-WVUK.7)
2023
- Lancaster, T. et al. 2023. Proof-of-concept recall-by-genotype study of extremely low and high Alzheimer’s polygenic risk reveals autobiographical deficits and cingulate cortex correlates. Alzheimer's Research and Therapy 15 213. (10.1186/s13195-023-01362-y)
- Chandler, H. L. et al. 2023. Reduced brain oxygen metabolism in patients with multiple sclerosis: Evidence from dual-calibrated functional MRI. Journal of Cerebral Blood Flow and Metabolism 43 (1), pp.115-128. (10.1177/0271678X221121849)
2022
- Chandler, H. et al. 2022. Alzheimer's genetic risk effects on cerebral blood flow across the lifespan are proximal to gene expression. Neurobiology of Aging 120 , pp.1-9. (10.1016/j.neurobiolaging.2022.08.001)
- Chiarelli, A. M. et al., 2022. A flow-diffusion model of oxygen transport for quantitative mapping of cerebral metabolic rate of oxygen (CMRO2) with single gas calibrated fMRI. Journal of Cerebral Blood Flow and Metabolism 42 (7), pp.1192-1209. (10.1177/0271678X221077332)
2021
- Steventon, J. et al. 2021. Changes in white matter microstructure and MRI-derived cerebral blood flow after one-week of exercise training. Scientific Reports 11 22061. (10.1038/s41598-021-01630-7)
- Shaw, A. D. et al. 2021. Tiagabine induced modulation of oscillatory connectivity and activity match PET-derived, canonical GABA-A receptor distributions. European Neuropsychopharmacology 50 , pp.34-45. (10.1016/j.euroneuro.2021.04.005)
- Murray, A. N. , Chandler, H. L. and Lancaster, T. M. 2021. Multimodal hippocampal and amygdala subfield volumetry in polygenic risk for Alzheimer's disease. Neurobiology of Aging 98 , pp.33-41. (10.1016/j.neurobiolaging.2020.08.022)
- Chandler, H. L. et al. 2021. Using dual-calibrated functional MRI to map brain oxygen supply and consumption in multiple sclerosis. BioRxiv
2020
- Smith, R. L. et al. 2020. Deep learning PET epilepsy detection with a novel symmetric loss convolutional autoencoder. Presented at: 2020 IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC) Boston, MA, USA 31 October - 7 November 2020. 2020 IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC). IEEE(10.1109/NSS/MIC42677.2020.9507980)
- Chandler, H. L. et al. 2020. Polygenic risk for Alzheimer's disease shapes hippocampal scene-selectivity. Neuropsychopharmacology 45 , pp.1171-1178. (10.1038/s41386-019-0595-1)
- Shaw, A. D. et al. 2020. GABAA receptor mapping in human using non-invasive electrophysiology. [Online].bioRxiv. Available at: https://doi.org/10.1101/2020.05.11.087726.
- Germuska, M. et al. 2020. A frequency-domain machine learning method for dual-calibrated fMRI mapping of oxygen extraction fraction (OEF) and cerebral metabolic rate of oxygen consumption (CMRO2). Frontiers in Artificial Intelligence 3 12. (10.3389/frai.2020.00012)
2019
- Chandler, H. L. et al. 2019. Polygenic impact of common genetic risk loci for Alzheimer's disease on cerebral blood flow in young individuals. Scientific Reports 9 467. (10.1038/s41598-018-36820-3)
- Germuska, M. et al. 2019. Dual-calibrated fMRI measurement of absolute cerebral metabolic rate of oxygen consumption and effective oxygen diffusivity. NeuroImage 184 , pp.717-728. (10.1016/j.neuroimage.2018.09.035)
Articles
- Wright, M. E. et al. 2026. Endocrine modulation of cortical and retinal baseline perfusion across the menstrual cycle. Journal of Cerebral Blood Flow and Metabolism 46 (7), pp.1889-1904. (10.1177/0271678X261421106)
- Davis, R. et al. 2026. Impact of apolipoprotein Ε4 (APOE ε4) on neuroimaging outcomes in cognitively healthy midlife adults: A systematic review. NeuroImage: Clinical 51 104035. (10.1016/j.nicl.2026.104035)
- Chandler, H. L. et al. 2026. Imaging brain vascular function in Cystic Fibrosis: an MRI study of cerebral blood flow and brain oxygenation. Journal of Cystic Fibrosis 25 (1), pp.166-171. (10.1016/j.jcf.2025.08.010)
- Lancaster, T. M. , Murphy, K. and Chandler, H. 2025. Reductions in brainstem volume as a key macrostructural indicator in at-risk populations for Alzheimer’s disease. Alzheimer's Research and Therapy 17 (1) 177. (10.1186/s13195-025-01829-0)
- Frost, F. J. et al., 2025. Managing an ageing cystic fibrosis population: challenges and priorities. European Respiratory Review 34 (176) 240261. (10.1183/16000617.0261-2024)
- Driver, I. D. et al. 2025. Velocity-selective arterial spin labelling bolus duration measurements: Implications for consensus recommendations. Imaging Neuroscience 3 00506.. (10.1162/imag_a_00506)
- Chandler, H. L. et al. 2025. Non‐APOE variants predominately expressed in smooth muscle cells contribute to the influence of Alzheimer's disease genetic risk on white matter hyperintensities. Alzheimer's & Dementia: The Journal of the Alzheimer's Association 21 (2) e14455. (10.1002/alz.14455)
- McNabb, C. B. et al. 2025. WAND: A multi-modal dataset integrating advanced MRI, MEG, and TMS for multi-scale brain analysis. Scientific Data 12 220. (10.1038/s41597-024-04154-7)
- Driver, I. D. et al. 2024. Breath-hold calibrated fMRI mapping of absolute cerebral metabolic rate of oxygen metabolism (CMRO2): an assessment of the accuracy and repeatability in a healthy adult population. Imaging Neuroscience 2 , pp.1-14. (10.1162/imag_a_00298)
- Lancaster, T. et al. 2023. Proof-of-concept recall-by-genotype study of extremely low and high Alzheimer’s polygenic risk reveals autobiographical deficits and cingulate cortex correlates. Alzheimer's Research and Therapy 15 213. (10.1186/s13195-023-01362-y)
- Chandler, H. L. et al. 2023. Reduced brain oxygen metabolism in patients with multiple sclerosis: Evidence from dual-calibrated functional MRI. Journal of Cerebral Blood Flow and Metabolism 43 (1), pp.115-128. (10.1177/0271678X221121849)
- Chandler, H. et al. 2022. Alzheimer's genetic risk effects on cerebral blood flow across the lifespan are proximal to gene expression. Neurobiology of Aging 120 , pp.1-9. (10.1016/j.neurobiolaging.2022.08.001)
- Chiarelli, A. M. et al., 2022. A flow-diffusion model of oxygen transport for quantitative mapping of cerebral metabolic rate of oxygen (CMRO2) with single gas calibrated fMRI. Journal of Cerebral Blood Flow and Metabolism 42 (7), pp.1192-1209. (10.1177/0271678X221077332)
- Steventon, J. et al. 2021. Changes in white matter microstructure and MRI-derived cerebral blood flow after one-week of exercise training. Scientific Reports 11 22061. (10.1038/s41598-021-01630-7)
- Shaw, A. D. et al. 2021. Tiagabine induced modulation of oscillatory connectivity and activity match PET-derived, canonical GABA-A receptor distributions. European Neuropsychopharmacology 50 , pp.34-45. (10.1016/j.euroneuro.2021.04.005)
- Murray, A. N. , Chandler, H. L. and Lancaster, T. M. 2021. Multimodal hippocampal and amygdala subfield volumetry in polygenic risk for Alzheimer's disease. Neurobiology of Aging 98 , pp.33-41. (10.1016/j.neurobiolaging.2020.08.022)
- Chandler, H. L. et al. 2021. Using dual-calibrated functional MRI to map brain oxygen supply and consumption in multiple sclerosis. BioRxiv
- Chandler, H. L. et al. 2020. Polygenic risk for Alzheimer's disease shapes hippocampal scene-selectivity. Neuropsychopharmacology 45 , pp.1171-1178. (10.1038/s41386-019-0595-1)
- Germuska, M. et al. 2020. A frequency-domain machine learning method for dual-calibrated fMRI mapping of oxygen extraction fraction (OEF) and cerebral metabolic rate of oxygen consumption (CMRO2). Frontiers in Artificial Intelligence 3 12. (10.3389/frai.2020.00012)
- Chandler, H. L. et al. 2019. Polygenic impact of common genetic risk loci for Alzheimer's disease on cerebral blood flow in young individuals. Scientific Reports 9 467. (10.1038/s41598-018-36820-3)
- Germuska, M. et al. 2019. Dual-calibrated fMRI measurement of absolute cerebral metabolic rate of oxygen consumption and effective oxygen diffusivity. NeuroImage 184 , pp.717-728. (10.1016/j.neuroimage.2018.09.035)
Conferences
- Wood, L. et al. 2025. Brain age is stable across the menstrual cycle: results from a high-density sampling study. Presented at: ISMRM & ISMRT Annual Meeting and Exhibition Honolulu, Hawaii, USA 10-15 May 2025. Proceedings of the 2025 ISMRM & ISMRT Annual Meeting and Exhibition. (10.58530/2025/4889)
- Wright, M. E. et al. 2024. OP-07 Retinal and cortical vascular function across the menstrual cycle. Presented at: Women in Vision UK Winter Meeting 2023 Cambridge, UK 12 December 2023. Vol. 9.(10.1136/bmjoo-2024-WVUK.7)
- Smith, R. L. et al. 2020. Deep learning PET epilepsy detection with a novel symmetric loss convolutional autoencoder. Presented at: 2020 IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC) Boston, MA, USA 31 October - 7 November 2020. 2020 IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC). IEEE(10.1109/NSS/MIC42677.2020.9507980)
Websites
- Shaw, A. D. et al. 2020. GABAA receptor mapping in human using non-invasive electrophysiology. [Online].bioRxiv. Available at: https://doi.org/10.1101/2020.05.11.087726.
Ymchwil
Addysgu
BSc Seicoleg - Dulliau Ymchwil ac Ystadegau
MSc Niwroddelweddu - MRI / fMRI dulliau a dadansoddiad
MSc Niwroddelweddu - sesiynau ymarferol MRI.
MSc Niwroddelweddu - Clybiau cyfnodolion
Bywgraffiad
Addysg israddedig
- Seicoleg gyda Niwroseicoleg (Anrh dosbarth cyntaf)
Addysg ôl-raddedig
- M.Sc Niwrodelweddu (Gwahaniaeth)
- Ph.D Niwrowyddoniaeth wybyddol a niwrodelweddu
Cyflogaeth
- Cydymaith ymchwil a ariannwyd gan MRC-CiC (Rhagfyr 2017 - Ebrill 2018)
- Gwobr Strategol Ymddiriedolaeth Wellcome Prifysgol Caerdydd cydymaith ymchwil ôl-ddoethurol (Ebrill 2018-2023)
- Croeso
News articles
Contact Details
[email protected]
+44 29208 74000 ext 20057
Canolfan Ymchwil Delweddu'r Ymennydd Prifysgol Caerdydd, Heol Maendy, Caerdydd, CF24 4HQ
+44 29208 74000 ext 20057
Canolfan Ymchwil Delweddu'r Ymennydd Prifysgol Caerdydd, Heol Maendy, Caerdydd, CF24 4HQ
